Review3 Biotech2020
Exploring the efficacy of antagonistic rhizobacteria as native biocontrol agents against tomato plant diseases.
Review in 3 Biotech, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Keystone taxa of phyllosphere microbiome confer resistance to citrus bacterial canker in pomelo via multiple mechanisms.Journal of integrative plant biology · 2026Article
- Microalgae and Plant Growth Promoting Rhizobacteria for Sustainable Agriculture: Biostimulants and Biofertilizers to Improve Soil Health and Plant Stress Resilience.Current microbiology · 2026Review
- Review
- Endophytic and antagonisticFrontiers in microbiology · 2025Article
- Eco-friendly control of fusarium wilt in tomato: molecular docking and functional analysis of ZnO nanoparticles and biostimulants.Frontiers in plant science · 2025Article
- Biopesticides: a Green Approach Towards Agricultural Pests.Applied biochemistry and biotechnology · 2024Review
- Use of ginger extract and bacterial inoculants for the suppression of Alternaria solani causing early blight disease in Tomato.BMC plant biology · 2024Article
- BioSolutions for Green Agriculture: Unveiling the Diverse Roles of Plant Growth-Promoting Rhizobacteria.International journal of microbiology · 2024Review
- Suppression of tomato wilt by cell-free supernatants of Acinetobacter baumannii isolates from wild cacao from the Colombian Amazon.World journal of microbiology & biotechnology · 2023Article
- Green Synthesized Silver Nanoparticles: A Novel Approach for the Enhanced Growth and Yield of Tomato against Early Blight Disease.Microorganisms · 2023Article
- Enhancing plant defense using rhizobacteria in processing tomatoes: a bioprospecting approach to overcoming Early Blight andFrontiers in microbiology · 2023Article
- Fungicidal and plant growth-promoting traits ofFrontiers in plant science · 2023Article
- Emulsifying Properties of Rhamnolipids and Their In Vitro Antifungal Activity against Plant Pathogenic Fungi.Molecules (Basel, Switzerland) · 2022Article
- New Insights intoMicroorganisms · 2022Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As the environmental and health concerns alert the necessity to move towards a sustainable agriculture system, biological approach using indigenous plant growth-promoting rhizobacteria (PGPR) gains a strong impetus in the field of plant disease control. In this context, the present review article addresses the usage of rhizospheric antagonistic bacteria as a suitable alternative to control tomato fungal diseases namely Fusarium wilt and early blight disease. Biological control has been considered to be an eco-friendly, safe and effective method for disease management. The inherent traits of PGPR to antagonize a pathogen through various mechanisms has been investigated extensively to utilize them as potent biocontrol agents (BCA). Hence, the article provides a detailed account on different biocontrol mechanisms displayed by BCA. It is also suggested that the use of bacterial consortium ensures consistent performance by BCA in field conditions. Likewise, this review also deals with the opportunities and obstacles faced during commercialization of these antagonistic bacteria as biocontrol agents in the market.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.